Literature DB >> 30684886

EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model.

Ryo Usuba1, Joris Pauty2, Fabrice Soncin3, Yukiko T Matsunaga4.   

Abstract

Elucidating the mechanisms underlying sprouting angiogenesis and permeability should enable the development of more effective therapies for various diseases, including retinopathy, cancer, and other vascular disorders. We focused on epidermal growth factor-like domain 7 (EGFL7) which plays an important role in NOTCH signaling and in the organization of angiogenic sprouts. We developed an EGFL7-knockdown in vitro microvessel model and investigated the effect of EGFL7 at a tissue level. We found EGFL7 knockdown suppressed VEGF-A-induced sprouting angiogenesis accompanied by an overproduction of endothelial filopodia and reduced collagen IV deposition at the basal side of endothelial cells. We also observed impaired barrier function which reflected an inflammatory condition. Furthermore, our results showed that proper formation of adherens junctions and phosphorylation of VE-cadherin was disturbed. In conclusion, by using a 3D microvessel model we identified novel roles for EGFL7 in endothelial function during sprouting angiogenesis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Endothelial cell junction; Epidermal growth factor-like domain 7 (EGFL7); In vitro 3D model; Vascular endothelial growth factor (VEGF); Vascular permeability

Mesh:

Substances:

Year:  2019        PMID: 30684886     DOI: 10.1016/j.biomaterials.2019.01.022

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer.

Authors:  Yi Zhang; Lei Zhou; Yixin Xu; Jingyu Zhou; Tao Jiang; Jiaqi Wang; Chao Li; Xiaoxiong Sun; Hu Song; Jun Song
Journal:  Angiogenesis       Date:  2022-05-03       Impact factor: 9.596

2.  Multi-Layered Human Blood Vessels-on-Chip Design Using Double Viscous Finger Patterning.

Authors:  Elise Delannoy; Géraldine Tellier; Juliette Cholet; Alice M Leroy; Anthony Treizebré; Fabrice Soncin
Journal:  Biomedicines       Date:  2022-03-29

3.  Epidermal growth factor-like domain multiple 6 (EGFL6) promotes the migration and invasion of gastric cancer cells by inducing epithelial-mesenchymal transition.

Authors:  Fu-Chun Huo; Wen-Tao Zhu; Xu Liu; Yun Zhou; Lan-Sheng Zhang; Jie Mou
Journal:  Invest New Drugs       Date:  2020-09-19       Impact factor: 3.850

Review 4.  MicroRNA-126: A new and promising player in lung cancer.

Authors:  Qijun Chen; Shuanghua Chen; Juanjuan Zhao; Ya Zhou; Lin Xu
Journal:  Oncol Lett       Date:  2020-11-12       Impact factor: 2.967

5.  Paeoniflorin Inhibits the Proliferation and Metastasis of Ulcerative Colitis-Associated Colon Cancer by Targeting EGFL7.

Authors:  Yunxia Wang; Yi Zhou; Hui Lin; Haiyan Chen; Shu Wang
Journal:  J Oncol       Date:  2022-08-28       Impact factor: 4.501

Review 6.  A Bloody Conspiracy- Blood Vessels and Immune Cells in the Tumor Microenvironment.

Authors:  Lisa Terrassoux; Hugo Claux; Salimata Bacari; Samuel Meignan; Alessandro Furlan
Journal:  Cancers (Basel)       Date:  2022-09-21       Impact factor: 6.575

Review 7.  The Multifaceted Roles of EGFL7 in Cancer and Drug Resistance.

Authors:  Beate Heissig; Yousef Salama; Satoshi Takahashi; Ko Okumura; Koichi Hattori
Journal:  Cancers (Basel)       Date:  2021-03-01       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.